MAPT and Alzheimer disease: A recent neuropathologic study of YKL-40 expression in human brain tissue identified a subset of astrocytes as the source of YKL-40 in AD.38 The same study identified a positive correlation between YKL-40 and tau immunoreactivity: a colocalization that implicates the YKL-40 in the AD pathologic cascade.